Lunch Talk Series

In the “Lunch Talk Series”, group leaders from BioMed X Innovation Center and the PostDoc Network of the German Cancer Research Center invite renowned life science researchers to join them for a scientific exchange on novel research approaches.

The monthly lunch talks are a great meeting opportunity for researchers and students in the field of life sciences, with focus on cell biology, immunology, bioinformatics, neuroscience and nanomaterials.

The talks begin with one hour of presentation followed by informal discussions and networking during a sponsored lunch.

Topic areas

  • Metabolism and Signaling in Cancer
  • Bioinformatics & Selective Kinase Inhibitors
  • Immunosuppressive Microenvironments of Tumors
  • Nanomaterial-Based Biosensors for Near-Patient Testing
  • Epigenetics and Chronic Obstructive Pulmonary Disease (COPD)
  • Tau-Mediated Neurodegeneration in Alzheimer’s Disease
  • Oral Biofilm Disruption
  • Brain Microcircuits in Psychiatric Diseases
  • DNA Damage in Cancer

Former Speakers

  • Simone Picelli, German Centre for Neurodegenerative Diseases (DZNE), Bonn, Germany, “Single-cell RNA-sequencing made simple, efficient and inexpensive”
  • Frank Pfrieger, Institute of Cellular and Integrative Neuroscience(INCI) CNRS, University of Strasbourg, France, “Neuron-glia interactions: models matter”
  • Amit Agarwal, Solomon H. Snyder Dept. of Neuroscience, Johns Hopkins University, Baltimore, USA, “Decoding Microdomain Calcium Signals in Astrocytes”
  • Simon Anders, University of Heidelberg, ZMBH, Heidelberg, Germany, “Diving in the Data Deluge: Interactive Tools for Visual Exploration of Big Data”
  • Matthias Leisegang, Goethe University Frankfurt, Germany, “Long Noncoding RNAs In the Control of Endothelial Gene Regulatory Networks”
  • Stefan Diez, B CUBE – Center for Molecular Bioengineering, Technical University Dresden, Germany, “Biomolecular Motors: From Biological Function to Nanotechnological Applications”
  • Mohamed Bentires-Alj, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland, “Cancer targeted therapy and tumor heterogeneity: Act locally think globally”
  • Michael N. Hall, Biozentrum, University of Basel, Switzerland, “mTOR signaling in growth and metabolism”
  • Bassem Hassan, Institut du Cerveau et de la Moëlle épinière – ICM (Brain and Spine Institute), Paris, France, “Transcriptional regulation of neurogenesis”
  • Harald Janovjak, Assistant Professor in Synthetic Physiology, Institute of Science and Technology Austria, “Synthetic physiology – Remote control of cellular signals”
  • Elias Hobeika, Research Group Leader, Institute for Immunology, Ulm University, Germany, “Maintenance of mature B-cells in health and disease”
  • Andreas Offenhäusser, Director at the Peter Grünberg Institute at FZ Jülich, Germany, “Bioelectronics: building connections between bio systems and electronics”
  • Ulrich Stelzl, Professor at the Institute of Pharmaceutical Sciences (IPW), Department of Pharmaceutical Chemistry, University of Graz, Austria, “Studying post-translational protein modification in a human protein interaction network context”
  • Jesus Gil, Cell Proliferation Group, MRC Clinical, Sciences Centre London, United Kingdom, “Linking senescence and inflammation: the senescenceassociated secretory phenotype (SASP)”
  • Dimitrios Tzalis, founder and CEO of Taros, “European Lead Factory: Boosting European Drug Discovery”
  • Janos Vörös, Institute for Biomedical Engineering, ETH Zurich, Switzerland: “Next generation biosensors based on nanotechnology, miniaturized immunofiltration, plasmonic coupled particles and molography.”
  • Oliver Rocks, Group Leader Rho GTPase Signaling, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany, “A systematic analysis of the Rho GEF/GAP regulatory proteins”
  • Markus Zweckstetter, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany, “Molecular mechanisms of Tau function and Alzheimer pathology”
  • Petr Broz, University Basel, Switzerland, “Molecular mechanisms of inflammasome assembly and signalling”
  • Thijn Brummelkamp, Netherlands Cancer Institute, Amsterdam, the Netherlands, “Genetics in haploid human cells to study disease networks”
  • Almut Schulze, Department of Biochemistry and Molecular Biology Theodor-Boveri-Institute, Biocenter, Würzburg, Germany, “Targeting cancer metabolism”
  • Stefan Knapp, Structural Genomics Consortium, University Frankfurt, Germany, “Strategies for the design of selective kinase chemical tools and their role in target validation”

Upcoming Lunch Talks